© Reuters. Today’s most important upgrades
By Davit Kirakosyan
Jefferies upgraded Moderna (NASDAQ:) to Buy from Hold and raised its price target to $275.00 from $170.00 on a significant new pipeline story and catalysts ahead. “New story is now PCV cancer vaccine opportunity, Phase III RSV data coming up, doublet and triplet virus vaccines in 2023,” mentioned the analysts.
Atlantic Equities upgraded Warner Music Group (NASDAQ:) to Overweight from Neutral and price target to $41.00 from $34.00, noting it sees additional upside if the music industry can deliver sustainable pricing growth.
JPMorgan upgraded Glaukos Corp (NYSE:) to Neutral from Underweight and cut its price target to $42.00 from $48.00, noting it is tentatively optimistic that stabilizing trends in the base business should support modest growth in 2023 ahead of an iDose launch that has been anticipated since the 2015 IPO.
MoffettNathanson upgraded Verizon Communications (NYSE:) to Market Perform from Underperform with a price target of $41.00.
Want to get this news first? Upgrade to InvestingPro for real-time market coverage.
#Todays #important #upgrades #Investing.com